New Anticoagulant Drugs
- 1 January 2001
- Vol. 119 (1), 95S-107S
- https://doi.org/10.1378/chest.119.1_suppl.95s
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction anginaThe American Journal of Cardiology, 1998
- Oligonucleotide inhibitors of human thrombin that bind distinct epitopesJournal of Molecular Biology, 1997
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Genes from the medicinal leech (Hirudo medicinalis) coding for unusual enzymes that specifically cleave endo-ɛ(γ-Glu)-Lys isopeptide bonds and help to dissolve blood clotsMolecular Genetics and Genomics, 1996
- Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393The Lancet, 1996
- A peptide derived from a tissue factor loop region functions as a tissue factor-factor VIIa antagonistBiochemistry, 1995
- Factor XI Activation by Thrombin and Factor XIaSeminars in Thrombosis and Hemostasis, 1993
- Hirudin therapy for heparin‐associated thrombocytopenia and deep venous thrombosisAmerican Journal of Hematology, 1993
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Destabilase, the novel ϵ-(??-Glu)-Lys isopeptidase with thrombolytic activityBlood Coagulation & Fibrinolysis, 1991